Early detection and treatment of heart failure can greatly improve an otherwise poor prognosis. Research from Mayo Clinic suggests artificial intelligence could be used to detect the condition even when no symptoms are present.
Pairing rheumatology expertise with the latest digital technologies, this app helps patients manage their treatment regimen with innovative and intuitive features.
Digital medicines, which span chronic conditions, mental health issues such as depression, anxiety, and addiction, is just one of the topics that will be offered at MedCity INVEST PharmaTech, a virtual conference scheduled for July 26. Learn how to take part or register today.
Climate change poses a huge threat to the chemical industry, as many facilities are located in low‐lying coastal areas such as the U.S. Gulf Coast, and vulnerable to damage from hurricanes and flooding. These natural disasters are becoming more common with climate change.
Bristol Myer Squibb is getting rights to BBP-398, a contender in the chase for drugs that address difficult-to-target KRAS mutations. Meanwhile, BridgeBio Pharma receives some needed cash as it restructures in the wake of the Phase 3 failure of its lead program late last year.
No comments